Building on the Strategic Framework published in 2021, this new document explains how it should be used. It includes a maturity/capability model to help companies identify how to develop so they can increase their maturity/capability level for any of the five strategic objectives. It is based on shared ‘real-world evidence’ from members who have contributed to how they achieve the level they are at with the people (organizations), systems (technologies) and process (operating procedures) they have invested in.
Viewing related articles
Digital plant maturity model (DPMM) version 2: A best practice guide to using the BioPhorum DPMM and assessment tool
What does the concept of ‘digital plant’ mean in biopharmaceutical manufacturing? How can it be defined, measured and transformed? What is needed to move up the maturity curve. These are all questions that a business needs to answer to establish a practical strategy to realize the opportunities that digital offers.
The biomanufacturing Digital Plant Maturity Model (DPMM) describes the stages of maturity from simple paper-based plants through to the fully automated and integrated ‘adaptive plant’ of the future. Combined with the maturity assessment tool the maturity model can help IT professionals and stakeholders establish the current digital maturity of a biopharmaceutical facility and facilitates agreement on the future state, goals and strategy to get there.
This second version increases consistency by leveling scores across dimensions; simplifies the model by reducing the number of enabling dimensions; and improves its utility by resetting the vision for levels 4 and 5, aligning them with the BioPhorum Technology Roadmap.